Navigation Links
JDRF Announces Two Partnerships to Develop Stable, Pumpable Glucagon to Support Advanced Generation Artificial Pancreas Systems
Date:6/20/2013

ter treat, prevent, and eventually cure T1D.

As the largest charitable supporter of T1D research, JDRF is currently sponsoring $530 million in scientific research in 17 countries. In 2012 alone, JDRF provided more than $110 million to T1D research. More than 80 percent of JDRF's expenditures directly support research and research-related education. In 2012 Forbes magazine named JDRF one of its five All-Star charities, citing the organization's efficiency and effectiveness.

For more information, please visit jdrf.org.

About Xeris Pharmaceuticals, Inc.
Xeris is a specialty pharmaceutical company based in Austin, Texas focused on improving injectable therapeutics by eliminating reconstitution, simplifying administration, and easing the pain of injections for patients and caregivers. In the diabetes space, Xeris is developing a stable, non-aqueous, injectable glucagon for the treatment of hypoglycemia. The company has developed a room-temperature stable formulation which is being leveraged for multiple opportunities ranging from a rescue pen (the G-Pen™) for treatment of severe hypoglycemia, to a pump-based formulation (G-Pump™ Glucagon) for use in a bi-hormonal artificial pancreas.

About LATITUDE Pharmaceuticals, Inc.
LPI is a leading drug formulation development group that incorporates innovative and leading-edge approaches into its client projects and into its own reformulation programs. The company is recognized for its success with highly insoluble drugs and for developing inventive approaches and intellectual property for its clients. LPI's internal programs focus on developing outlicense-ready 505(b)(2) NDA opportunities.


'/>"/>
SOURCE JDRF
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Orexigen Therapeutics Announces Upcoming Clinical Data Presentations at American Diabetes Association Annual Scientific Meeting
2. Valeant Pharmaceuticals Announces Exercise Of Over-Allotment Option
3. Haemonetics Announces Next Steps in Manufacturing Transformation
4. Echo Therapeutics Announces Closing of Public Offering of Common Stock And Full Exercise of Over-Allotment Option by the Underwriter
5. BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research
6. Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital
7. NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinsons Disease
8. Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes
9. Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock
10. Specialty Coating Systems Announces New Antimicrobial Parylene Technology
11. Apama Medical Announces Issuance Of Patent For Low Profile Electrodes For Use On Balloons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)...  EndoChoice today announced the launch of its initial ... which will represent 25.6% of its outstanding common stock ... corporation in connection with the offering. The initial ... $15 and $17 per share. The underwriters for the ... up to an additional 937,500 shares of EndoChoice common ...
(Date:5/26/2015)... LONDON , May 26, 2015 ... that technology,s commercial potential ,What,s the future of ... and commercial predictions from 2015. Stay ahead there ... tests, you explore sales results, R&D, opportunities and ... visiongain shows you what,s possible for ...
(Date:5/26/2015)... , May 26, 2015  Array BioPharma ... its Chief Executive Officer, Ron Squarer , ... Conference in New York City. The public is welcome ... on the Array BioPharma website.Event: Jefferies 2015 Global ... 2015Time:1:30 p.m. Eastern Time Webcast: www.arraybiopharma.com  About Array ...
Breaking Medicine Technology:EndoChoice Announces Launch of Its Initial Public Offering 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 3Cell-Based Assays: World Industry and Market Prospects 2015-2025 4Cell-Based Assays: World Industry and Market Prospects 2015-2025 5Cell-Based Assays: World Industry and Market Prospects 2015-2025 6Cell-Based Assays: World Industry and Market Prospects 2015-2025 7
... YORK, Feb. 9, 2011 Reportlinker.com announces that ... its catalogue: Cetuximab - Comprehensive ... Eliminate unnecessary risk with the ... Pipeline Developer is a regularly updated, professional patent ...
... 9, 2011 Reportlinker.com announces that a ... its catalogue: Global Physician ... Treatment 2011 http://www.reportlinker.com/p0377969/Global-Physician-Survey-on-Stents-Stent-Grafts-and-Vulnerable-Plaque-Treatment-2011.html ... responses of a comprehensive survey conducted of ...
Cached Medicine Technology:Reportlinker Adds Cetuximab - Comprehensive patent search 2Reportlinker Adds Cetuximab - Comprehensive patent search 3Reportlinker Adds Cetuximab - Comprehensive patent search 4Reportlinker Adds Global Physician Survey on Stents, Stent-Grafts and Vulnerable Plaque Treatment 2011 2
(Date:5/26/2015)... 2015 National Prevention Week , National ... It is supported by the Substance Abuse and Mental ... awareness of, and action about, substance abuse as well ... coalitions are encouraged to join in promoting prevention strategies, ... issues, and in building community partnerships. , The Voice ...
(Date:5/26/2015)... 2015 i2i Systems, the leader in ... than 15 years, has earned 2014 Patient Centered Medical ... Assurance (NCQA) for its flagship product i2iTracks , ... the work we have done to create healthier populations ... acknowledgement from NCQA once again,” said Janice Nicholson, co-founder ...
(Date:5/26/2015)... New York, NY (PRWEB) May 26, 2015 ... show for a good cause. "The photography show will connect ... difference in their lives.” For the last five years, Raul ... pictures to convey the notion that we are not bounded ... Quechua, a language spoken in Raul’s native country, Bolivia. The ...
(Date:5/26/2015)... 2015 Adenna, Inc ., worldwide ... excited to announce the launch of Enov8 ... made of polyethylene (PE) and approved by the U.S. ... , The Enov8 glove might look like ... mixing salads but our proprietary formula and production technology ...
(Date:5/26/2015)... Viejo, CA (PRWEB) May 26, 2015 ... styles for Final Cut Pro X . ... suspenseful to simple and elegantly styled text. , ... in seconds. , ProTrailer Network can easily complement any ... style desired and within seconds can make professional looking ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Takes Part in National Prevention Week 2Health News:Narconon Arrowhead Takes Part in National Prevention Week 3Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 2Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 3Health News:A Photographer & Two Educational Organiazations Join to Make a Difference in Our Youth 2Health News:Enov8® Exam Glove by Adenna® Approved by U.S. FDA 2Health News:Developers at Pixel Film Studios Release ProTrailer Network for Final Cut Pro X 2
... A latest men’s health survey has revealed that men over ... in their 30s or 40s. Their level of satisfaction approximates ... interesting study are published in the February issue of BJU ... 185 Norway men ranged between 20 and 79 years of ...
... Tinnitus is a problem where people are plagued all round their ... from it since she was three. She describes it as the ... a metal spiral staircase. After 25 years later she says that ... an exhibition designer tells that it drives her crazy. Statistics show ...
... UK. The recent reports that many women will be barred from ... caused a lot of commotion among them. // ... 13,000 deaths are expected. But recently the Association of British Insurers ... genetic breast cancer tests. , But it was also ...
... logs, maintained by teenagers from age 13 to 17, ... personal information, //thus making them vulnerable to cyber stalking ... in the technology and social behavior program, will be ... American Association for the Advancement of Science in St. ...
... Immune cells destroy the myelin sheath that surrounds nerve ... myelin is very essential in transmitting the impulses across the ... the metals aluminium and iron in the urine of people ... said that MS could be linked to difficulty in processing ...
... that the euthanasia campaigner Dr Philip Nitschke does not possess ... ,The workshop informs participants of their legal rights about ending ... to be registered as a doctor to carry out his ... denies that he needs a licence. He faces a criminal ...
Cached Medicine News:Health News:50 Plus Men More Satisfied With Sex Life 2Health News:Tinnitus: a problem which is still ambiguous 2Health News:Health insurance in the future would depend on genetic test results 2Health News:Teens need to Exercise Caution While Using Online Blogs 2Health News:Aluminium and Iron Could Play a Vital Role in Multiple Sclerosis 2
... to remove a cast from an arm or ... patients are cut or burned by the cast ... professionals to remove any cast with confidence. This ... cuts and burns from the cast saw and ...
... choice plays an important part in ... particularly where reduced capsule formation, inflammation ... considerations. GORE-TEX Suture, a nonabsorbable, ePTFE ... characteristics sought by a variety of ...
... GORE-TEX ACUSEAL Cardiovascular Patch ... it to "seal" around penetrating ... bleeding by as much as ... with improved suture retention, multi-directional ...
... Vascular Grafts have met the challenges ... Recognized for exceptional performance and quality, ... renowned surgeons worldwide. These grafts require ... spread of infection, and ensure utmost ...
Medicine Products: